Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer’s Disease1
Xiaoguang Liu, Michaeline Hebron, Sanjana Mulki, et al.
Journal of Alzheimer s Disease (2019) Vol. 72, Iss. 2, pp. 425-441
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Marlene F. Schmidt, Zhong Yan Gan, David Komander, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 570-590
Open Access | Times Cited: 282
Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 187
The Protective Effect of Cyanidin‐3‐Glucoside on Myocardial Ischemia‐Reperfusion Injury through Ferroptosis
Xin Shan, Zhiyang Lv, Mengjiao Yin, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 122
X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Yan Yan, Xinming Wang, Dale Chaput, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3913-3930.e19
Open Access | Times Cited: 82
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Jinwang Ye, Hua-Li Wan, Sihua Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1489-1498
Open Access | Times Cited: 22
Progressive Supranuclear Palsy Syndrome: An Overview
Eduardo Ichikawa-Escamilla, Rodrigo A Velasco-Martínez, Laura Adalid‐Peralta
IBRO Neuroscience Reports (2024) Vol. 16, pp. 598-608
Open Access | Times Cited: 7
Proteostasis in neurodegenerative diseases
Sumit Kinger, Yuvraj Anandrao Jagtap, Prashant Kumar, et al.
Advances in clinical chemistry (2024), pp. 270-333
Closed Access | Times Cited: 6
Deubiquitinases in Neurodegeneration
Abudu I. Bello, Rituparna Goswami, Shelby L. Brown, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 556-556
Open Access | Times Cited: 25
USP10 deubiquitinates Tau, mediating its aggregation
Zhen Wei, Kuan Zeng, Jichang Hu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 21
USP13: Multiple Functions and Target Inhibition
Xiaolong Li, Ge Yang, Wenyao Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Dysregulated proteostasis network in neuronal diseases
Ching-San Tseng, Yu-Wen Chao, Yi-Hsiang Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 13
Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases
Ankit Siwach, Harit Patel, Amit Khairnar, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access
Roles of Ubiquitin Ligases and Deubiquitylases in Alzheimer’s Disease
Fengju Jia, Lin Fu
Molecular Neurobiology (2025)
Closed Access
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer’s disease
Fanglin Weng, Ling He
Neurobiology of Aging (2020) Vol. 99, pp. 79-85
Closed Access | Times Cited: 32
Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases
Hyeon‐Ah Do, Kwang‐Hyun Baek
Ageing Research Reviews (2021) Vol. 69, pp. 101367-101367
Closed Access | Times Cited: 25
The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases
Na Liu, Miaomiao Lin, Yan Wang
Molecular Neurobiology (2022) Vol. 60, Iss. 1, pp. 247-263
Open Access | Times Cited: 16
Role of USP13 in physiology and diseases
Qian Wang, Zhenzhen Sun, Weiwei Xia, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 15
Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology
Xiaoguang Liu, Kaluvu Balaraman, Ciarán C. Lynch, et al.
Metabolites (2021) Vol. 11, Iss. 9, pp. 622-622
Open Access | Times Cited: 19
New insights into the therapeutic approaches for the treatment of tauopathies
Himanshi Singh, Asmita Das, Mohammad Moshahid Khan, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1020-1026
Open Access | Times Cited: 7
Regulatory Role of Ubiquitin Specific Protease-13 (USP13) in Misfolded Protein Clearance in Neurodegenerative Diseases
Xiaoguang Liu, Charbel Moussa
Neuroscience (2021) Vol. 460, pp. 161-166
Closed Access | Times Cited: 16
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Biying Qin, Xiaohong Chen, Feng Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Inhibition of Ubiquitin-Specific Protease-13 Improves Behavioral Performance in Alpha-Synuclein Expressing Mice
Xiaoguang Liu, Kaluvu Balaraman, Ciarán C. Lynch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8131-8131
Open Access | Times Cited: 8
Acetylation of AMPA Receptors Regulates Receptor Trafficking and Rescues Memory Deficits in Alzheimer's Disease
Margaret O’Connor, Yangping Shentu, Guan Wang, et al.
iScience (2020) Vol. 23, Iss. 9, pp. 101465-101465
Open Access | Times Cited: 11
Promoting proteostasis by cAMP/PKA and cGMP/PKG
Md Salim Ahammed, Xuejun Wang
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top